Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Cellular therapies offer a promising therapeutic strategy for the highly malignant brain tumor, glioblastoma (GBM). However, their clinical translation is limited by the lack of effective target identification and stringent testing in pre-clinical models that replicate standard treatment in GBM pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhere, Deepak, Choi, Sung Hugh, van de Donk, Pim, Hope, David, Gortzak, Kiki, Kunnummal, Amina, Khalsa, Jasneet, Revai Lechtich, Esther, Reinshagen, Clemens, Leon, Victoria, Nissar, Nabil, Bi, Wenya Linda, Feng, Cheng, Li, Hongbin, Zhang, Yu Shrike, Liang, Steven H., Vasdev, Neil, Essayed, Walid Ibn, Quevedo, Pablo Valdes, Golby, Alexandra, Banouni, Naima, Palagina, Anna, Abdi, Reza, Fury, Brian, Smirnakis, Stelios, Lowe, Alarice, Reeve, Brock, Hiller, Arthur, Chiocca, E. Antonio, Prestwich, Glenn, Wakimoto, Hiroaki, Bauer, Gerhard, Shah, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120173/
https://www.ncbi.nlm.nih.gov/pubmed/35589724
http://dx.doi.org/10.1038/s41467-022-30558-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120173/
https://www.ncbi.nlm.nih.gov/pubmed/35589724
http://dx.doi.org/10.1038/s41467-022-30558-3

Ejemplares similares